Sequent Scientific projects ₹4,000 crore revenue in FY27, eyes leadership in animal health
Published on: Nov. 19, 2025, 3:24 p.m. | Source: CNBC TV18
Hari Babu, Group CEO of Sequent Scientific–Viyash Lifesciences, said the company aims to strengthen its presence in both human and animal health over the long term. However, he emphasised that the main focus remains on animal health.
